Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG

/R E P E A T -- Notice to the media - COVID-19 Update (October 20, 2020) - The Prime Minister, Ministers and Government of Canada officials to hold a news conference on coronavirus disease/


OTTAWA, ON, Oct. 20, 2020 /CNW/ - The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

Date
October 20, 2020

Time
11:30 AM (EDT)

Location
Sir John A Macdonald Building, Room 200
144 Wellington Street, Ottawa, Ontario

The media availability will also be held by teleconference.
Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number: 613-954-9003

Passcode: 6822783#

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 17:31
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...

at 17:26
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...

at 17:05
Antibe Announces TSX Delisting Review
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Toronto Stock Exchange ("TSX") is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Company's financial...

at 16:30
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Viatris Inc.  will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the...

at 16:30
WELL Health to Expand its Canadian Clinic Network with Acquisition from Shoppers Drug Mart Inc. of Medical Clinics operating as "The Health Clinic by Shopperstm"
WELL Health Clinic Network Inc. ("WELL"), a subsidiary of WELL Health Technologies Corp. , a digital healthcare company focused on...

at 16:25
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
Precision BioSciences, Inc. , an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain...

More news about Health...


News published on and distributed by: